Larimar Therapeutics logo
Larimar Therapeutics LRMR
$ 6.16 1.23%

Quarterly report 2024-Q3
added 10-30-2024

report update icon

Larimar Therapeutics EV/EBITDA Ratio 2011-2024 | LRMR

Annual EV/EBITDA Ratio Larimar Therapeutics

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-0.256 -2.43 0.173 0.371 0.148 0.395 0.235 - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
0.395 -2.43 -0.195